Notably, our initial analysis suggested the important role of PYCR2 in promoting CRC aggressiveness, as only PYCR2, out of PYCR1, PYCR2, and PYCR3/PYCRL, showed a significant association with poor patient survival. This evidence concerns the gene PYCR1 and colorectal carcinoma.